Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,884 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.
Maekawa T, Kato S, Kawamura T, Takada K, Sone T, Ogata H, Saito K, Izumi T, Nagao S, Takano K, Okada Y, Tachi N, Teramoto M, Horiuchi T, Hikota-Saga R, Endo-Umeda K, Uno S, Osawa Y, Kobayashi A, Kobayashi S, Sato K, Hashimoto M, Suzu S, Usuki K, Morishita S, Araki M, Makishima M, Komatsu N, Kimura F. Maekawa T, et al. Among authors: sato k. Blood. 2019 Sep 5;134(10):814-825. doi: 10.1182/blood.2019000051. Epub 2019 Jul 3. Blood. 2019. PMID: 31270105 Free article.
CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.
Watanabe J, Sato K, Osawa Y, Horiuchi T, Kato S, Hikota-Saga R, Maekawa T, Yamamura T, Kobayashi A, Kobayashi S, Kimura F. Watanabe J, et al. Among authors: sato k. Int J Hematol. 2018 Jul;108(1):47-57. doi: 10.1007/s12185-018-2436-0. Epub 2018 Mar 29. Int J Hematol. 2018. PMID: 29600428
[Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study].
Teramoto M, Sone T, Takada K, Ogata H, Saito K, Izumi T, Takano K, Nagao S, Okada Y, Tachi N, Kawamura T, Kato S, Maekawa T, Kobayashi A, Kobayashi S, Sato K, Kimura F. Teramoto M, et al. Among authors: sato k. Rinsho Ketsueki. 2020;61(6):598-604. doi: 10.11406/rinketsu.61.598. Rinsho Ketsueki. 2020. PMID: 32624531 Japanese.
Sudden blast phase in chronic myeloid leukemia developed during nilotinib therapy after major molecular response was achieved.
Okada Y, Sato K, Kobayashi S, Nagao S, Takano K, Teramoto M, Tachi N, Kawamura T, Horiuchi T, Kato S, Saga R, Maekawa T, Yamamura T, Watanabe J, Kobayashi A, Kimura F. Okada Y, et al. Among authors: sato k. Int J Hematol. 2018 Apr;107(4):495-497. doi: 10.1007/s12185-017-2354-6. Epub 2017 Oct 14. Int J Hematol. 2018. PMID: 29032513
14,884 results
You have reached the last available page of results. Please see the User Guide for more information.